Pharmacokinetic Disposition of Zidovudine during Pregnancy
Zidovudine pharmacokinetics was determined in three human immunodeficiency virus type I-seropositive women receiving zidovudine (200 mg orally every 4 h) from 19 to 39 weeks ofpregnancy and postpartum. Zidovudine concentrations were measured using high-pressure liquid chromatography, and pharmacokin...
Gespeichert in:
Veröffentlicht in: | The Journal of infectious diseases 1991-02, Vol.163 (2), p.226-232 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!